Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMRN – Amarin Corp ADR

Amarin Corporation plc
AMRN
$14.89
Name : Amarin Corporation plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $312,230,016.00
EPSttm : -1.68
finviz dynamic chart for AMRN
Amarin Corporation plc
$14.89
4.86%
$0.69
AMRN — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

2.97

Margin Of Safety %

-27

Put/Call OI Ratio

0.16

EPS Next Q Diff

0.19

EPS Last/This Y

1.79

EPS This/Next Y

0.99

Price

14.89

Target Price

12.5

Analyst Recom

4

Performance Q

-6.73

Upside

-480.8%

Beta

0.82

Ticker: AMRN




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11AMRN14.940.160.063116
2026-05-12AMRN14.950.170.003115
2026-05-13AMRN15.050.170.133116
2026-05-14AMRN14.770.170.043153
2026-05-15AMRN14.50.172.403215
2026-05-18AMRN14.150.150.072247
2026-05-19AMRN14.080.150.052439
2026-05-20AMRN14.320.140.022488
2026-05-21AMRN14.580.130.072778
2026-05-22AMRN14.40.130.002836
2026-05-26AMRN14.390.131.652858
2026-05-27AMRN14.550.150.002972
2026-05-28AMRN14.490.150.393033
2026-05-29AMRN14.520.150.003060
2026-06-02AMRN14.530.150.383114
2026-06-03AMRN14.540.150.103141
2026-06-04AMRN13.80.150.583143
2026-06-05AMRN13.930.160.163187
2026-06-08AMRN14.230.160.073205
2026-06-09AMRN14.90.160.703150
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11AMRN14.94-111.5- -0.01
2026-05-12AMRN14.95-111.5- -0.01
2026-05-13AMRN15.11-111.5- -0.01
2026-05-14AMRN14.72-111.5- -0.01
2026-05-15AMRN14.47-111.5- -0.01
2026-05-18AMRN14.06-111.5- -0.01
2026-05-19AMRN14.10-111.5- -0.01
2026-05-20AMRN14.32-111.5- -0.01
2026-05-21AMRN14.62-111.5- -0.01
2026-05-22AMRN14.47-111.5- -0.01
2026-05-26AMRN14.35-111.5- -0.01
2026-05-27AMRN14.52-111.5- -0.01
2026-05-28AMRN14.40-111.5- -0.01
2026-05-29AMRN14.51-111.5- -0.01
2026-06-01AMRN14.44-100.0- -0.01
2026-06-02AMRN14.55-100.0- -0.01
2026-06-03AMRN14.50-100.0- -0.01
2026-06-04AMRN13.83-100.0- -0.01
2026-06-05AMRN13.92-100.0- -0.01
2026-06-08AMRN14.20-100.0- -0.01
2026-06-09AMRN14.89-100.0- -0.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11AMRN0.000.022.04
2026-05-12AMRN0.000.023.23
2026-05-13AMRN0.000.023.23
2026-05-14AMRN0.000.023.23
2026-05-15AMRN0.000.023.23
2026-05-18AMRN0.00-1.063.23
2026-05-19AMRN0.00-1.063.23
2026-05-20AMRN0.00-1.063.23
2026-05-21AMRN0.00-1.063.23
2026-05-22AMRN0.00-1.063.23
2026-05-26AMRN0.000.323.23
2026-05-27AMRN0.000.323.23
2026-05-28AMRN0.000.322.97
2026-05-29AMRN0.000.322.97
2026-06-02AMRN0.000.322.97
2026-06-03AMRN0.000.322.97
2026-06-04AMRN0.000.322.97
2026-06-05AMRN0.000.322.97
2026-06-08AMRN0.000.322.97
2026-06-09AMRN0.000.322.97
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

Institutional Transactions

0.32

Beta

0.82

Average Sales Estimate Current Quarter

44

Average Sales Estimate Next Quarter

44

Fair Value

10.88

Quality Score

43

Growth Score

36

Sentiment Score

13

Actual DrawDown %

87.5

Max Drawdown 5-Year %

-93.1

Target Price

12.5

P/E

Forward P/E

270.73

PEG

P/S

1.44

P/B

0.7

P/Free Cash Flow

EPS

-1.62

Average EPS Est. Cur. Y​

-0.01

EPS Next Y. (Est.)

0.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-15.52

Relative Volume

2.65

Return on Equity vs Sector %

-35

Return on Equity vs Industry %

-45.5

EPS 1 7Days Diff

-0.8

EPS 1 30Days Diff

-0.79

EBIT Estimation

AMRN Healthcare
$14.89
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
6/25
Volume
3/15
Valuation
9/20
TP/AR
0/10
Options
8/10
RSI
57.2
Range 1M
65.7%
Sup Dist
6.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
42 /100
WEAK
Momentum
5/25
Growth
23/30
Estimates
2/20
Inst/Vol
6/15
Options
6/10
EPS Yr
61.1%
EPS NY
257.1%
52W%
35.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +53.9% upside
Quality
5/30
Valuation
15/30
Growth
19/25
Stability
7/10
LT Trend
1/5
Upside
+53.9%
Quality
43
MoS
-27%
Amarin Corporation plc
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 80
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
AMRN

Latest News

Caricamento notizie per AMRN
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading